Novo Nordisk's semaglutide beats its counterpart liraglutide to become the next generation of weight loss innovation, and then Eli Lilly's GLP-1R/GIPR dual-target agonist tirzepatide achieves a 22.5% weight loss, surpassing semaglutide's weight loss history
Warfarin Retatrutide can impact the pharmacokinetics of warfarin, potentially influencing the INR and blood clotting
[1] [2] Patients should store these medications in the main body of the refrigerator rather than in the door, where temperature fluctuations are more common
Your travel kit stays simpler, and you eliminate the stress of injecting in hotel rooms or airport bathrooms
Dietary patterns that support GLP-1 biology may also help people tolerate GLP-1 receptor agonist (GLP-1RA) therapy by reducing gastrointestinal side effects, which are a frequent reason for discontinuation in clinical practice
Ledo JH, Azevedo EP, Beckman D, Ribeiro FC, Santos LE, Razolli DS, et al